GRACEcast
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Visit Show Website http://cancerGRACE.org/Recently Aired
-
HD
Immunotherapy for Non-Squamous NSCLC: Should We be Using Biomarker Selection?
The immune checkpoint inhibitor Opdivo (nivolumab) shows better efficacy than ...
The immune checkpoint inhibitor Opdivo (nivolumab) shows better efficacy than Taxotere (docetaxel) for advanced non-squamous NSCLC, but this was seen only in patients with PD-L1 protein expression on their tumor. Should we be using this as a biomarker?
-
HD
Immunotherapy for Squamous Non-Small Cell Lung Cancer
Research released at the 2015 American Society of Clinical Oncology ...
Research released at the 2015 American Society of Clinical Oncology (ASCO) annual meeting showed great promise for squamous cell lung cancer patients taking the immunotherapy drug Opdivo (nivolumab). But can we predict which patients will do well on it?
-
HD
Whole Brain Radiation for Brain Metastases
Radiation Oncologist Dr. Vivek Mehta reviews the concept of using ...
Radiation Oncologist Dr. Vivek Mehta reviews the concept of using whole brain radiation for multiple brain metastases, including how it is delivered and risks and benefits of this strategy.
-
HD
Serum Testing for Molecular Markers: Circulating Tumor Cells & Circulating Free DNA
Dr. Jack West reviews new techniques for evaluating mutations from ...
Dr. Jack West reviews new techniques for evaluating mutations from blood, including detection of circulating tumor cells (CTCs) or mutations in circulating free DNA (cfDNA) that can replace at least some tissue biopsies.
-
HD
Myths and Misconceptions About Bronchioloalveolar Carcinoma (BAC)
Unfortunately, there is as much misinformation as good information about ...
Unfortunately, there is as much misinformation as good information about the unusual subtupe of lung cancer known as bronchioloalveolar carcinoma (BAC) or adenocarcinoma in situ. Dr. Jack West reviews the top 5 myths.
-
HD
Bronchioloalveolar Carcinoma (BAC): What is It?
Bronchioloalveolar carcinoma (BAC), also known as adenocarcinoma in situ, is ...
Bronchioloalveolar carcinoma (BAC), also known as adenocarcinoma in situ, is an unusual subtype of lung cancer with its own appearance under a microscope and on imaging. Dr. Jack West introduces some of the basics of the unique features of BAC.
-
HD
Questions & Answers with Drs. Pal, Luke and Wolchok about Immunotherapy for Cancer
Immunotherapy Forum Video #31: "You know the world is changing ...
Immunotherapy Forum Video #31: "You know the world is changing when you have to change the rules..." Following presentations on endpoints and biomarkers in cancer immunotherapy, the doctors take questions from the audience.
-
HD
Redefining Success and Failure in Cancer Immunotherapy Trials
Immunotherapy Forum Video #30: Immunotherapy for cancer has rewritten the ...
Immunotherapy Forum Video #30: Immunotherapy for cancer has rewritten the rules for what we consider a successful response to treatment. Some tumors grow before they regress. Dr. Jedd Wolchok discusses why a new measurement criteria was developed.
-
HD
The Future of Cancer Immunotherapy: Combination Treatments
Immunotherapy Forum Video #29: In part 2 of 2, Dr. ...
Immunotherapy Forum Video #29: In part 2 of 2, Dr. Jason Luke discusses treating cancer with immunotherapy and another drug, such chemotherapy or targeted therapies, as well as what we know about biomarkers that predict if an immunotherapeutic will work.
-
HD
The Right Time for Cancer Immunotherapy: Before or After Surgery?
Immunotherapy Forum Video #28: Doctors are still weighing the pros ...
Immunotherapy Forum Video #28: Doctors are still weighing the pros and cons of giving a cancer patient immunotherapy before or after resection surgery. In part 1 of 2 videos, Dr. Jason Luke details those risks and benefits.
